Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
Type:
Grant
Filed:
September 11, 2017
Date of Patent:
October 13, 2020
Assignee:
Integral Health, Inc.
Inventors:
Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland